Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melike Melikoğlu(Istanbul University-Cerrahpaşa), Hasan Yazıcı(Yazd University), Sebahattin Yurdakul(Istanbul University), Vedat Hamuryudan(Access to Wholistic and Productive Living Institute), İzzet Fresko(Access to Wholistic and Productive Living Institute), Cem Mat(Access to Wholistic and Productive Living Institute), Yılmaz Özyazgan(Access to Wholistic and Productive Living Institute), Feride Göğüş
PubMed
January 1, 2005
Cited by 293
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
The Long-Term Mortality and Morbidity of Behçet Syndrome
|Medicine|2003|757
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
A Controlled Trial of Azathioprine in Behçet's Syndrome
|New England Journal of Medicine|1990|646
Behçet syndrome: a contemporary view
|Nature Reviews Rheumatology|2018|438